MILWAUKEE, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (TWIN), today announced that it will release its fiscal 2025 first-quarter results at approximately 8:00 am Eastern on November 6, 2024, ...
Disc Medicine, Inc. will hold a conference call on January 21, 2025, at 8:00 am EST to discuss feedback from the FDA regarding its investigational drug, bitopertin, for treating Erythropoietic ...
Twin Disc, Incorporated (NASDAQ:TWIN) Q4 2025 Earnings Call Transcript August 21, 2025 Twin Disc, Incorporated misses on earnings expectations. Reported EPS is $0.1019 EPS, expectations were $0.26.
Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations. Disc Medicine, Inc. recently provided positive updates ...
MILWAUKEE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the ...
MILWAUKEE, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN) today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the ...
MILWAUKEE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2026 first-quarter results at approximately 8:00 am Eastern on November 5, ...
MILWAUKEE, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results